BioSpace News Archive

Business

Opentrons’ subsidiary Neochromosome and Mekonos announce new partnership to advance cell engineering for personalized medicine

Mekonos, Inc., a biotech platform company building the future of cell therapies on a chip, has announced a new partnership with Neochromosome, Inc., a wholly-owned subsidiary of Opentrons Labworks focused on the creation of genome-scale cell engineering solutions.

December 14, 2021
·
3 min read
Computer Aided Detection (CAD) Market To Reach USD 1579.5 Million By 2028, Says Reports and Data

Rising adoption of digital breast tomosynthesis and government initiatives to support and provide advanced imaging technologies are fueling global market growth.

December 14, 2021
·
7 min read
Hybrid Operating Room Market Size to Reach USD 2,366.9 Million in 2028 Growing at a CAGR of 2.7%, according to Emergen Research

According to Emergen Research, the global hybrid operating room market size was USD 925.8 Million in 2020 and is expected to reach USD 2,366.9 Million in 2028 and register a revenue CAGR of 12.4% during the forecast period, 2021-2028.

December 14, 2021
·
7 min read
Oncolytic Virus Therapies Market Size to Reach USD 609.7 Million in 2028 Growing at a CAGR of 26.2%, according to Emergen Research

According to Emergen Research, the global oncolytic virus therapies market size was USD 94.7 million in 2020 and is expected to reach USD 609.7 million in 2028 and register a revenue CAGR of 26.2% during the forecast period, 2021-2028.

December 14, 2021
·
8 min read
Biotech Bay

Agilent to Present at Goldman Sachs and J.P. Morgan Healthcare Conferences

Agilent Technologies Inc. (NYSE: A) today announced the company will deliver presentations at the Goldman Sachs 14th Annual Healthcare CEOs Unscripted Conference and the J.P. Morgan 40th Annual Healthcare Conference.

December 14, 2021
·
1 min read
Single Use/Disposable Endoscopy Market Size to Reach USD 6.29 Billion in 2028 Growing at a CAGR of 21.1%, according to Emergen Research

According to Emergen Research, the global single use/disposable market size was USD 1.35 billion in 2020 and is expected to reach USD 6.29 billion in 2028 and register a revenue CAGR of 21.1% during the forecast period, 2021-2028.

December 14, 2021
·
7 min read
Lexaria’s Clinical Hypertension Study HYPER-H21-3 Nears Completion

Lexaria Bioscience Corp. announces that its human clinical study HYPER-H21-3 is expected to complete all dosing and sample collection this week.

December 14, 2021
·
5 min read
Bio NC

Sparta Biomedical Raises $5M in Series Seed Financing to Advance its Breakthrough Device for Partial Knee Resurfacing

Sparta Biomedical, a privately held medical device company targeting partial knee resurfacing, announced the closing of an oversubscribed Series Seed round of financing to complete preclinical activities for IDE submission.

December 14, 2021
·
3 min read
BioMidwest

Exicure, Inc. Announces $11.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

The gross proceeds to the Company from this offering are expected to be approximately $11.5 million, before deducting the placement agent’s fees and other offering expenses payable by the Company.

December 14, 2021
·
5 min read
Policy

Government of Canada announces the release of the latest results from the Canadian Health Measures Survey

The Honourable Jean-Yves Duclos, Minister of Health, announces the release of the Sixth Report on Human Biomonitoring of Environmental Chemicals in Canada featuring recent results from the Canadian Health Measures Survey cycle 6.

December 14, 2021
·
3 min read